NCT00373087View on ClinicalTrials.gov

COMT Polymorphism and Entacapone Efficacy

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Parkinson's Disease
Interventions
DRUG

entacapone

entacapone

DRUG

l dopa versus placebo

l dopa versus placebo

Trial Locations (1)

75013

Centre d'Investigation Clinique, Hôpital de la Pitié-Salpétrière,, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00373087 - COMT Polymorphism and Entacapone Efficacy | Biotech Hunter | Biotech Hunter